Screener
Aura Biosciences, Inc. AURA Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Accounts payable | 1,024 | (298) |
| Accrued expenses and other liabilities | (2,745) | (2,475) |
| Operating lease liabilities | (386) | (325) |
| Net cash used in operating activities | (29,893) | (23,355) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (102) | (187) |
| Maturities of marketable securities | 55,000 | 30,000 |
| Net cash provided by investing activities | 54,898 | 29,813 |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s operating cash flow?
- Aura Biosciences, Inc. (AURA) reported operating cash flow of -$29.89M in Q1 2026.
- How has Aura Biosciences, Inc.'s operating cash flow changed year-over-year?
- Aura Biosciences, Inc.'s operating cash flow decreased by 28.0% year-over-year, from -$23.36M to -$29.89M.
- What is the long-term trend for Aura Biosciences, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s operating cash flow has grown at a 27.2% compound annual growth rate (CAGR), from -$32.41M to -$84.74M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Aura Biosciences, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude